Company Overview of Mersana Therapeutics, Inc.
Mersana Therapeutics, Inc. is a biotechnology company that discovers, engineers, and develops antibody drug conjugates to cure various cancers. The company develops immune conjugate therapies to create drugs that enhance patients’ lives. It offers XMT-1522, a drug therapy for tumor models that express relatively low amounts of the HER2 protein; and human anti-HER2 antibody used in XMT-1522. Mersana Therapeutics, Inc. has strategic alliances with Takeda Pharmaceutical Company Limited; Merck Serono; and Asana BioSciences. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics, Inc. in November 2005. Mersana Therapeutics, Inc. was founded in 2001 and is ...
840 Memorial Drive
Cambridge, MA 02139
Founded in 2001
Key Executives for Mersana Therapeutics, Inc.
Chief Executive Officer, President and Director
Vice President of Finance
Compensation as of Fiscal Year 2016.
Mersana Therapeutics, Inc. Key Developments
Mersana Therapeutics Appoints Kristen Hege, M.D., to Board of Directors
Sep 6 16
Mersana Therapeutics, Inc. announced the appointment of Kristen M. Hege, M.D., to its board of directors. Since 2010, Dr. Hege has served as Celgene Corporation’s medical lead for Translational Development, currently as a Corporate Vice President, where she is responsible for early phase development of the company’s significant oncology and hematology pipeline.
Mersana Therapeutics, Inc. Presents at The 23rd Annual NewsMakers in the Biotech Industry Conference, Sep-09-2016
Aug 16 16
Mersana Therapeutics, Inc. Presents at The 23rd Annual NewsMakers in the Biotech Industry Conference, Sep-09-2016. Venue: Millennium Broadway Hotel & Conference Center, New York, New York, United States. Presentation Date(s): Sep-09-2016.
Mersana Therapeutics, Inc. Presents at 2016 Credit Suisse Antibody Day, Sep-07-2016 12:40 PM
Aug 10 16
Mersana Therapeutics, Inc. Presents at 2016 Credit Suisse Antibody Day, Sep-07-2016 12:40 PM. Venue: Credit Suisse Offices, One Madison Avenue at 24th Street, 12th Floor, New York, New York, United States. Speakers: Timothy B. Lowinger, Chief Scientific Officer.
Similar Private Companies By Industry
Recent Private Companies Transactions
June 15, 2016